Q3 Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Q3 Asset Management's VRTX Position: Q4 2022 in Review
Q3 Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2022, closing a stake of 943 shares — an estimated $275K sold.
Q3 Asset Management first reported a position in VRTX in Q2 2022 and held it in 2 quarters. The position peaked at $345K in Q2 2022. 1,222 funds tracked by Wall St. Rank hold VRTX as of Q4 2022.
- Q3 Asset Management reported no remaining Vertex Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Q3 Asset Management sold 943 Vertex Pharmaceuticals shares in Q4 2022, an estimated $275K.
- Q3 Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2022 and held it in 2 quarters.
- Q3 Asset Management's Vertex Pharmaceuticals position peaked at $345K in Q2 2022.
- 1,222 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2022.
Based on Q3 Asset Management's 13F filing for Q4 2022, filed 2 Feb 2023.